Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hydrocephalus 1Headache 1Gallbladder Neoplasms 1Female Breast Carcinoma 1Epilepsy 1Disease Progression 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Brain Edema 1Abdominal Neoplasms 1

Interventions

Pirinitramide 2Morphine 2Zoledronic Acid 1Standard of Care 1Sevoflurane 1Propofol 1Injections, Epidural 1Ethiodized Oil 1Epirubicin 1Diphosphonates 1Desflurane 1Chemoembolization, Therapeutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplastic Cells, Circulating × Sevoflurane × Clear all
NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Hong Kong Children's Hospital

Phase 4 Recruiting
100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡